Fastner, Christian http://orcid.org/0000-0001-9367-4386
Müller, Claus
Brachmann, Johannes
Lewalter, Thorsten
Akin, Ibrahim
Sievert, Horst
Käunicke, Matthias
Zeymer, Uwe
Hochadel, Matthias
Schneider, Steffen
Senges, Jochen
Erkapic, Damir
Weiß, Christian
Funding for this research was provided by:
Stiftung Institut für Herzinfarktforschung
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 28 February 2023
Accepted: 12 May 2023
First Online: 1 June 2023
Declarations
:
: This study was approved by the ethics committee of the Landesärztekammer Rheinland‐Pfalz (Mainz, Germany) as well as local ethics committees of the participating centers and was performed in accordance with the Helsinki Declaration. Prior to participation, informed consent was obtained from all patients.
: CF received consultant fees from Bayer Vital GmbH (Leverkusen, Germany) and AstraZeneca GmbH (Hamburg, Germany). TL received speaker honoraria from Abbott (Chicago, IL, USA), Boston Scientific (Marlborough, MA, USA), and Lifetech Sciences (Shenzhen, China). HS received study honoraria to his institution, reimbursement for travel expenses, and consulting fees from Abbott (Chicago, IL, USA), Boston Scientific (Marlborough, MA, USA), Lifetech Sciences (Shenzhen, China), and Occlutech GmbH (Jena, Germany). His relationships with industry are limited to reimbursement for clinical trials. Personal honoraria have not been paid. The other authors do not disclose any conflicts of interest.